Brain+ partners with German medical distributor – and advances launch of its first CST dementia product in Germany to Q2 2023
Copenhagen, Denmark, September 28, 2022 – Brain+ A/S (Nasdaq First North: BRAINP)
· Through Coopmed, Brain+ will be represented by experienced and local medical sales managers in Germany and begin to build the customer pipeline in preparation for the commercial launch of its first CST dementia product, CST-Therapist Companion · In partnership with Rox Health (part of Roche Germany), Brain+ has successfully completed the regulatory and commercial preparation of CST-Therapist Companion for the German market and now advances its launch plan with six months to Q2 2023 · The German